CDI Laboratories Inc (AKA: CDI~Custom-Designed Immunologics) Profile last edited on: 2/7/23
CAGE: 4QNC0
UEI: NR84J164RKG5
Business Identifier: Proteome microarray technology: next generation proteomics 
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
12 West Mendez Vigo Avenue 2nd Floor
Mayaguez, PR 00680
Mayaguez, PR 00680
| (939) 280-5293 |
| info@cdi-lab.com |
| www.cdi-lab.com |
Location: Single
Congr. District: 00
County: Mayaguez
Congr. District: 00
County: Mayaguez
Public Profile
Headquartered in Baltimore, MD with ties to Johns Hopkins but also having research facilities in Puerto Rico, CDI Laboratories, Inc. (CDI) is a biotechnology company delivering products and services founded on whole human proteome microarray technology. The companyâs products and services are designed to overcome great hurdles that are currently slowing down advancements in the proteomics field in the areas of research, and protein-based therapeutics and diagnostics. CDI has a series of patent-pending platform technologies that are allowing the company to develop novel products, to provide unparalleled services and offer accelerating partnership opportunities. In January 2023 it was announced that BroadOak Capital Partners had acquired CDI Laboratories for an undisclosed amount
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
20-24Revenue Range
2M-2.5MVC funded?
YesPublic/Private
Privately HeldStock Info
----IP Holdings
5-9Awards Distribution by Agency
Most Recent SBIR Projects
| Year | Phase | Agency | Total Amount | |
|---|---|---|---|---|
| 2016 | 1 | NIH | $294,320 | |
| Project Title: Monospecific Monoclonal Antibodies Against Human Protein Complexes on an Interactome-Wide Scale. | ||||
| 2016 | 1 | NIH | $154,596 | |
| Project Title: Validation of Immune-Based Biomarkers for Endometriosis | ||||
| 2010 | 1 | NIH | $290,854 | |
| Project Title: Antigen-Microarray Validated Monoclonal Antibody Library for Analysis of Brain-Ex | ||||
Key People / Management
Ignacio Pino -- Chief Executive Officer; Co-Founder
Seth Blackshaw
Daniel Eichinger -- Chief Scientific Officer; Co-Founder
Idhaliz Flores
Shaohui Hu -- Director, Proteomic Sciences
Tyler Hulett -- Director, Platform Innovation
John Paul Lacava
Scott Paschke -- Vice President of Sales and Business Developmen
Seth Blackshaw
Daniel Eichinger -- Chief Scientific Officer; Co-Founder
Idhaliz Flores
Shaohui Hu -- Director, Proteomic Sciences
Tyler Hulett -- Director, Platform Innovation
John Paul Lacava
Scott Paschke -- Vice President of Sales and Business Developmen
